Scarica l'app Stockscreener
142.85
1.09%
-1.57
Dopo l'orario di chiusura:
142.40
-0.45
-0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BX Giù?
Forum
Previsione
Storia dei dividendi
Blackstone Inc Borsa (BX) Ultime notizie
Blackstone’s alternative narratives - Financial Times
Blackstone Funding Deal Might Change the Case For Investing In Merck (MRK) - simplywall.st
Blackstone president says businesses should worry about AI disruption - Nikkei Asia
Private Equity Must Sell More Assets — at Whatever Price - Bloomberg.com
Blackstone-Backed Food Sanitation Cleaner Inks Workout Deal - Bloomberg.com
Blackstone scores rare premium in Boston office building sale - The Business Times
Blackstone Scores Rare Premium in Boston Office Building Sale - Bloomberg.com
Despite payout cut, Blackstone BDC 'expects' a strong November, president Jonathan Gray says - InvestmentNews
Sector Update: Health Care Stocks Rise Late Afternoon - MarketScreener
Private Credit Dealmakers Face Years of Heavy Lifting in Japan - Bloomberg.com
The Every Company's Series D, Apollo's $6.5b wind farm bet, and Blackstone invests in Merck - Axios
Key facts: Blackstone reports $54.2B inflows; to acquire Hologic for $18.3B; buys stake in TriMas for $1.45B - TradingView
SEI gatekeepers drop T. Rowe for Blackstone on $3.2bn high-yield strategy - Citywire
Merck & Co. secures $700M from Blackstone to fund lead ADC sac-TMT - FirstWord Pharma
Merck Entering $700 Million R&D Funding Agreement With Blackstone Life Sciences - Pulse 2.0
Blackstone $1.45bn CMBS oversubscribed - GlobalCapital
Royalty Pharma Buys Royalty Interest in Alnylam Pharmaceuticals' Amvuttra From Blackstone Life Sciences for $310 Million - MarketScreener
Bain Lines Up $3.1 Billion Private Loan for Service Logic Buy - Bloomberg.com
Merck & Co Receive $700 Million From Blackstone to Boost Cancer Drug Development - USA Herald
Blackstone Injecting $700M Into Merck Cancer Therapy - Law360
Merck secures $700 million funding from Blackstone to develop cancer therapy - Reuters
Earnings call transcript: Black Stone Minerals Q3 2025 beats expectations - Investing.com
Private equity powering AI boom at public cost - Private Equity Stakeholder Project PESP
Merck & Blackstone Enter Research and Development Funding Agreement - Contract Pharma
Blackstone-backed Nexus Select Trust eyes multiple mall acquisitions - livemint.com
Merck strikes financing agreement with Blackstone - MarketScreener
Merck to Receive $700 Million From Blackstone Unit to Support Experimental Cancer Drug Development - MarketScreener
Merck writes tale of 2 checks, bagging $700M from Blackstone and spending $150M to regain asset - Fierce Biotech
Merck (MRK) Secures $700M from Blackstone for Cancer Therapy Dev - GuruFocus
Merck clinches $700 million from Blackstone to develop ADC for cancer - PharmaLive
TriMas Enters Into Agreement to Sell TriMas Aerospace for $1.45 Billion - Yahoo Finance
Merck to receive $700M from Blackstone to develop cancer therapy - MSN
Merck inks $700M deal with Blackstone for cancer drug (MRK) - Seeking Alpha
Blackstone (BX) Invests in Merck's Cancer Treatment Development - GuruFocus
Corton Capital Inc. Invests $327,000 in Blackstone Inc. $BX - MarketBeat
Blackstone to pay Merck $700M to fund development of antibody-drug conjugate - Endpoints News
Wellington Shields Capital Management LLC Grows Stake in Blackstone Inc. $BX - MarketBeat
Royalty Pharma (NASDAQ: RPRX) acquires 1% AMVUTTRA royalty for $310M from Blackstone - Stock Titan
Merck secures $700 million from Blackstone to fund cancer drug development - Investing.com
Blackstone pays Merck $700M to buy into ADC drug royalties - Yahoo Finance
Merck, Blackstone Life Sciences sign R&D funding deal for sacituzumab tirumotecan (sac-TMT) - MarketScreener
Merck and Blackstone enter research agreement to develop cancer therapy for $700 million - MarketScreener
Ex-Blackstone, Partners Group Execs Raise $1.1B for APAC Real Estate Secondaries - Mingtiandi
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT) - MarketScreener
Merck receives $700 million from Blackstone for cancer drug development - StreetInsider
Bank of New York Mellon Corp Sells 288,843 Shares of Blackstone Inc. $BX - MarketBeat
FERC urged to reject Blackstone’s New Mexico utility takeover - Southwest Ledger
Royalty Pharma acquires royalty stake in Alnylam’s Amvuttra from Blackstone for $310m - pehub.com
Blackstone Inc. $BX Shares Sold by Freestone Capital Holdings LLC - MarketBeat
Bank of Montreal Can Lowers Stock Holdings in Blackstone Inc. $BX - MarketBeat
Blackstone’s Gray: We may seek faster exits to avoid AI disruption risk - Private Equity International | PEI
Could Blackstone’s (BX) Moves in Europe and Retirement Markets Redefine Its Competitive Edge? - simplywall.st
Blackstone Mortgage Trust, Inc. (BXMT) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Blackstone VP and Progress Together CEO to address female leaders at FN event - Financial News London
Blackstoneissues $1.2 billion in senior notes due 2030 and 2036SEC filing - MarketScreener
Hologic Tops Expectations And Receives Buyout Offer From Blackstone - Finimize
Blackstone Group Completes $1.2 Billion Senior Notes Offering - TipRanks
Blackstone completes $1.2 billion senior notes offering - Investing.com
Blackstone Completes Senior Notes Offering - The Joplin Globe
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 - Stock Titan
News | Blackstone secures $1.45 billion CMBS loan for 94-property industrial portfolio - CoStar
Rethinking the 60% - Blackstone
Hedge Fund and Insider Trading News: Scott Bessent, Ray Dalio, Warren Buffett, D.E. Shaw, Davidson Kempner, Millennium Management, Blackstone Inc (BX), Service Corporation International (SCI), and More - Insider Monkey
Blackstone appoints head of CLOs - Pensions & Investments
Leonard Green Is Leading a $1 Billion Ares Continuation Fund - Bloomberg
Blackstone firm launches $3bn Saudi data centre venture - Global Construction Review
Sunday’s Insider Moves: Top Execs Make Million-Dollar Trades on Friday - Investing.com
0.56%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):